_id

695fb2bdc2e91020a7bd410a

Ticker

0D53.LSE

Name

Financiere de Tubize SA

Exchange

LSE

Address

Allée de la Recherche 60, Brussels, Belgium, 1070

Country

UK

Sector

Industry

Currency

EUR

Website

https://www.financiere-tubize.be

Description

Financière de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's principal products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Briviact, Vimpat, and Keppra for the treatment of epilepsy partial-onset seizures; Nayzilam, a nasal spray; and Neupro for treating Parkinson's disease and restless legs syndrome. It also offers Zyrtec and Xyzal for the treatment of allergy; Nootropil for the treatment of psycho-organic syndromes or cognitive decline and cortical myoclonus; and Xyrem for use in treating narcolepsy with cataplexy in adult patients. The company's products in pipeline include padsevonil for drug resistant epilepsy; UCB0107 for treating progressive supranuclear palsy; UCB0599 for Parkinson's disease; UCB7858 for auto-inflammatory diseases; bimekizumab to treat psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; and dapirolizumab pegol for systemic lupus erythematosus. Financière de Tubize S.A. is based in Brussels, Belgium.

Last Close

227

Volume

-

Current Price

227

Change

-0.5

Last Updated

2026-01-08T13:35:57.112Z

Ipo Date

-

Market Cap

10176257024

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2019-06-30

Revenue

-

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

293500

Operating Income

-293500

Interest Expense

347000

Pretax Income

73584000

Net Income

73584000

Eps

-

Dividends Per Share

12463500

Shares Outstanding

44548600

Income Tax Expense

-

EBITDA

-

Operating Margin

-

Total Other Income Expense Net

73877500

Cash

1023000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

1074000

Property Plant Equipment

-

Total Assets

2551918000

Payables

-

Short Term Debt

53004000

Long Term Debt

33697000

Total Liabilities

87239000

Equity

2464679000

Bs_currency_symbol

EUR

Depreciation

-

Change In Working Capital

-

Cash From Operations

-304000

Capital Expenditures

0

Cash From Investing

41186500

Cash From Financing

-41135500

Net Change In Cash

-253000

Cf_currency_symbol

EUR

PE

0.2664

PB

-

ROE

2.985540916281593

ROA

2.8834782308835942

FCF

-304000

Fcf Percent

-

Piotroski FScore

2

Health Score

50

Deep Value Investing Score

5.5

Defensive Investing Score

5

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

4

Net Net Investing Score

1

Quality Investing Score

3

Value Investing Score

5.5

Quarters > 0 > quarter

2019-06-30

Quarters > 0 > income Statement > revenue

-

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

293500

Quarters > 0 > income Statement > operating Income

-293500

Quarters > 0 > income Statement > interest Expense

347000

Quarters > 0 > income Statement > pretax Income

73584000

Quarters > 0 > income Statement > net Income

73584000

Quarters > 0 > income Statement > eps

-

Quarters > 0 > income Statement > dividends Per Share

12463500

Quarters > 0 > income Statement > shares Outstanding

-

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

73877500

Quarters > 0 > income Statement > currency_symbol

EUR

Quarters > 0 > balance Sheet > cash

1023000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

1074000

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

2551918000

Quarters > 0 > balance Sheet > payables

-

Quarters > 0 > balance Sheet > short Term Debt

53004000

Quarters > 0 > balance Sheet > long Term Debt

33697000

Quarters > 0 > balance Sheet > total Liabilities

87239000

Quarters > 0 > balance Sheet > equity

2464679000

Quarters > 0 > balance Sheet > currency_symbol

EUR

Quarters > 0 > cash Flow > net Income

73584000

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

-304000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

41186500

Quarters > 0 > cash Flow > cash From Financing

-41135500

Quarters > 0 > cash Flow > net Change In Cash

-253000

Quarters > 0 > cash Flow > currency_symbol

EUR

Quarters > 0 > ratios > PE

-

Quarters > 0 > ratios > PB

-

Quarters > 0 > ratios > ROE

2.985540916281593

Quarters > 0 > ratios > ROA

2.8834782308835942

Quarters > 0 > ratios > FCF

-304000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

50

Quarters > 1 > quarter

2019-03-31

Quarters > 1 > income Statement > revenue

-

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

293500

Quarters > 1 > income Statement > operating Income

-293500

Quarters > 1 > income Statement > interest Expense

347000

Quarters > 1 > income Statement > pretax Income

73584000

Quarters > 1 > income Statement > net Income

73584000

Quarters > 1 > income Statement > eps

-

Quarters > 1 > income Statement > dividends Per Share

12463500

Quarters > 1 > income Statement > shares Outstanding

-

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

73877500

Quarters > 1 > income Statement > currency_symbol

EUR

Quarters > 1 > balance Sheet > cash

1023000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

1074000

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

2551918000

Quarters > 1 > balance Sheet > payables

-

Quarters > 1 > balance Sheet > short Term Debt

53004000

Quarters > 1 > balance Sheet > long Term Debt

33697000

Quarters > 1 > balance Sheet > total Liabilities

87239000

Quarters > 1 > balance Sheet > equity

2464679000

Quarters > 1 > balance Sheet > currency_symbol

EUR

Quarters > 1 > cash Flow > net Income

73584000

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-

Quarters > 1 > cash Flow > cash From Operations

-304000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

41186500

Quarters > 1 > cash Flow > cash From Financing

-41135500

Quarters > 1 > cash Flow > net Change In Cash

-253000

Quarters > 1 > cash Flow > currency_symbol

EUR

Quarters > 1 > ratios > PE

-

Quarters > 1 > ratios > PB

-

Quarters > 1 > ratios > ROE

2.985540916281593

Quarters > 1 > ratios > ROA

2.8834782308835942

Quarters > 1 > ratios > FCF

-304000

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

50

Quarters > 2 > quarter

2018-12-31

Quarters > 2 > income Statement > revenue

-

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

153500

Quarters > 2 > income Statement > operating Income

-153500

Quarters > 2 > income Statement > interest Expense

363000

Quarters > 2 > income Statement > pretax Income

43818500

Quarters > 2 > income Statement > net Income

43818500

Quarters > 2 > income Statement > eps

-

Quarters > 2 > income Statement > dividends Per Share

12463500

Quarters > 2 > income Statement > shares Outstanding

-

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

43972000

Quarters > 2 > income Statement > currency_symbol

EUR

Quarters > 2 > balance Sheet > cash

1529000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

102000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

1662000

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

2483601000

Quarters > 2 > balance Sheet > payables

104000

Quarters > 2 > balance Sheet > short Term Debt

53184000

Quarters > 2 > balance Sheet > long Term Debt

90318000

Quarters > 2 > balance Sheet > total Liabilities

144038000

Quarters > 2 > balance Sheet > equity

2339563000

Quarters > 2 > balance Sheet > currency_symbol

EUR

Quarters > 2 > cash Flow > net Income

43818500

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

-

Quarters > 2 > cash Flow > cash From Operations

-253000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

41186500

Quarters > 2 > cash Flow > cash From Financing

210000

Quarters > 2 > cash Flow > net Change In Cash

120000

Quarters > 2 > cash Flow > currency_symbol

EUR

Quarters > 2 > ratios > PE

-

Quarters > 2 > ratios > PB

-

Quarters > 2 > ratios > ROE

1.8729352447444245

Quarters > 2 > ratios > ROA

1.7643131887932078

Quarters > 2 > ratios > FCF

-253000

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

48

Quarters > 3 > quarter

2018-09-30

Quarters > 3 > income Statement > revenue

-

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

153500

Quarters > 3 > income Statement > operating Income

-153500

Quarters > 3 > income Statement > interest Expense

363000

Quarters > 3 > income Statement > pretax Income

43818500

Quarters > 3 > income Statement > net Income

43818500

Quarters > 3 > income Statement > eps

-

Quarters > 3 > income Statement > dividends Per Share

12463500

Quarters > 3 > income Statement > shares Outstanding

-

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

43972000

Quarters > 3 > income Statement > currency_symbol

EUR

Quarters > 3 > balance Sheet > cash

1529000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

102000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

1662000

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

2483601000

Quarters > 3 > balance Sheet > payables

104000

Quarters > 3 > balance Sheet > short Term Debt

53184000

Quarters > 3 > balance Sheet > long Term Debt

90318000

Quarters > 3 > balance Sheet > total Liabilities

144038000

Quarters > 3 > balance Sheet > equity

2339563000

Quarters > 3 > balance Sheet > currency_symbol

EUR

Quarters > 3 > cash Flow > net Income

43818500

Quarters > 3 > cash Flow > depreciation

-

Quarters > 3 > cash Flow > change In Working Capital

-

Quarters > 3 > cash Flow > cash From Operations

-253000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

41186500

Quarters > 3 > cash Flow > cash From Financing

210000

Quarters > 3 > cash Flow > net Change In Cash

120000

Quarters > 3 > cash Flow > currency_symbol

EUR

Quarters > 3 > ratios > PE

-

Quarters > 3 > ratios > PB

-

Quarters > 3 > ratios > ROE

1.8729352447444245

Quarters > 3 > ratios > ROA

1.7643131887932078

Quarters > 3 > ratios > FCF

-253000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

48

Valuation > metrics > PE

0.2664

Valuation > final Score

70

Valuation > verdict

97.3% Undervalued

Profitability > metrics > ROE

2.985540916281593

Profitability > metrics > ROA

6851.3966480446925

Profitability > final Score

51

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.035395684387297496

Risk > metrics > Interest Coverage

-0.845821325648415

Risk > final Score

57

Risk > verdict

High

Liquidity > metrics > Current Ratio

0.020262621688929137

Liquidity > metrics > Quick Ratio

0.020262621688929137

Liquidity > final Score

11

Liquidity > verdict

Weak

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

51

Prev Profitabilities > 1

49

Prev Profitabilities > 2

49

Prev Risks > 0

57

Prev Risks > 1

58

Prev Risks > 2

58

Prev Liquidities > 0

11

Prev Liquidities > 1

12

Prev Liquidities > 2

12

Updated At

2026-01-20T23:13:09.157Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-03-21

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-